ULIVI, PAOLA
 Distribuzione geografica
Continente #
EU - Europa 785
AS - Asia 729
NA - Nord America 597
AF - Africa 58
SA - Sud America 27
OC - Oceania 3
Totale 2.199
Nazione #
US - Stati Uniti d'America 591
DE - Germania 232
CN - Cina 228
SG - Singapore 223
IT - Italia 169
HK - Hong Kong 102
SE - Svezia 95
VN - Vietnam 87
GB - Regno Unito 59
NL - Olanda 56
CI - Costa d'Avorio 40
FR - Francia 39
FI - Finlandia 32
IE - Irlanda 30
IN - India 28
BR - Brasile 23
RU - Federazione Russa 23
KR - Corea 20
BG - Bulgaria 19
ID - Indonesia 16
TG - Togo 13
JO - Giordania 11
UA - Ucraina 9
AT - Austria 7
BE - Belgio 6
CA - Canada 5
TR - Turchia 4
CH - Svizzera 3
AR - Argentina 2
AU - Australia 2
EE - Estonia 2
JP - Giappone 2
PL - Polonia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
BH - Bahrain 1
BO - Bolivia 1
HU - Ungheria 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MU - Mauritius 1
MX - Messico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
TH - Thailandia 1
Totale 2.199
Città #
Singapore 215
Hefei 111
Hong Kong 102
Fairfield 56
Santa Clara 52
Chandler 51
Ashburn 47
Southend 45
Krefeld 41
Abidjan 40
Dublin 30
Bologna 28
Dong Ket 28
Boardman 25
Wilmington 25
Woodbridge 24
Princeton 23
Seattle 23
Seoul 20
Ann Arbor 19
Milan 19
Sofia 19
Helsinki 16
Houston 16
Jakarta 16
Bad Bellingen 15
Cambridge 14
Hanoi 14
Frankfurt am Main 13
Lomé 13
Potenza 13
Ho Chi Minh City 12
Amman 11
Munich 11
Rome 11
Falkenstein 10
Los Angeles 10
Düsseldorf 8
Lappeenranta 8
Nuremberg 8
Turku 8
Berlin 7
Cesena 7
Guangzhou 7
Jacksonville 6
Nanjing 6
Redmond 6
Chicago 5
Naples 5
San Diego 5
Westminster 5
Brussels 4
Faenza 4
Florence 4
Forlì 4
Jinan 4
Lauterbourg 4
Lucca 4
Rimini 4
Salt Lake City 4
San Lazzaro di Savena 4
Teggiano 4
Turin 4
Vienna 4
Bern 3
Bühl 3
Da Nang 3
Des Moines 3
Elk Grove Village 3
Hyderabad 3
Matera 3
Phoenix 3
Prescot 3
Saint Petersburg 3
San Francisco 3
São Paulo 3
Toronto 3
Bari 2
Beijing 2
Bexley 2
Biên Hòa 2
Cagliari 2
Genoa 2
Hangzhou 2
Imola 2
Jurbise 2
Linfen 2
London 2
Monticello d'Alba 2
Nha Trang 2
Padova 2
Pisa 2
Rio de Janeiro 2
Shenzhen 2
Tampa 2
Tokyo 2
Vũng Tàu 2
Zhengzhou 2
Abeokuta 1
Amsterdam 1
Totale 1.464
Nome #
Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer 189
Schedule-dependent cytotoxic interaction between Epidoxorubicin and Gemcitabine in human bladder cancer cells in vitro. 171
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 169
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 129
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma 117
Sorafenib and Regorafenib in HBV- or HCV-positive hepatocellular carcinoma patients: Analysis of RESORCE and SHARP trials. 97
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 85
Epigenetic mechanisms in gastric cancer: Potential new therapeutic opportunities 82
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 80
Moving beyond parp inhibition: Current state and future perspectives in breast cancer 72
Genetic and epigenetic alterations of cdh1 regulatory regions in hereditary and sporadic gastric cancer 71
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress 66
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 63
Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation 62
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy 60
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications 55
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 53
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer 53
Tumor-Infiltrating Lymphocytes (TILs) and Risk of a Second Breast Event After a Ductal Carcinoma in situ 52
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients 45
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study 40
Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension 38
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 37
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 35
The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies’ integration 32
Genomic Profiling of Extensive Stage Small-Cell Lung Cancer Patients Identifies Molecular Factors Associated with Survival 31
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement 30
Genomic events stratifying prognosis of early gastric cancer 27
The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer 26
Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients 26
The Role of TP53 Mutations in EGFR-Mutated Non-Small-Cell Lung Cancer: Clinical Significance and Implications for Therapy 25
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis 24
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab 24
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer 23
Liquid Biopsy for EGFR Mutation Analysis in Advanced Non-Small-Cell Lung Cancer Patients: Thoughts Drawn from a Real-Life Experience 22
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations 21
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer 20
Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test? 19
New generation anaplastic lymphoma kinase inhibitors 15
Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer 13
Role of liquid biopsy in oncogene-addicted non-small cell lung cancer 12
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer 12
Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis 3
Targeting RET-rearranged non-small-cell lung cancer: future prospects 2
Totale 2.328
Categoria #
all - tutte 7.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 0 0 0 11
2020/2021138 13 12 7 2 0 3 1 9 13 2 22 54
2021/2022246 5 0 16 24 18 6 4 31 7 17 80 38
2022/2023283 17 42 17 27 18 27 4 21 63 4 22 21
2023/2024311 7 20 9 9 28 17 21 13 159 10 11 7
2024/20251.187 61 89 54 92 80 41 30 34 42 197 201 266
Totale 2.328